MPM BioImpact LLC - 31 Dec 2025 SCHEDULE 13G Report for Climb Bio, Inc. Common Stock, par value $0.0001 per share (CLYM)

Filing Manager: MPM BioImpact LLC
Reporting Manager: MPM BioImpact LLC
Security: Climb Bio, Inc. Common Stock, par value $0.0001 per share
Symbol: CLYM
Shares outstanding: 47,705,000 shares
Disclosed Ownership: 2,671,480 shares
Ownership: 5.6%
Form type: SCHEDULE 13G
Filing time: 17 Feb 2026, 16:09:59 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Quoteable Key Fact

"MPM BioImpact LLC disclosed 5.6% ownership in Climb Bio, Inc. Common Stock, par value $0.0001 per share (CLYM) on 31 Dec 2025."

Quick Takeaways

MPM BioImpact LLC filed SCHEDULE 13G for Climb Bio, Inc. Common Stock, par value $0.0001 per share (CLYM).
Disclosed ownership: 5.6%.
Date of event: 31 Dec 2025.

What Changed

No earlier schedule filing is available for direct comparison.
Current filing was accepted on 17 Feb 2026, 16:09.

Why This Matters

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
MPM BioImpact LLC	5.6%	2,671,480	2,671,480	0	Christopher Wolf	Chief Financial Officer

Explore related SEC datasets

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .